Replies to post #86092 on Biotech Values

[ariadndndough]

donshimoda nice to have you posting here. look forward to all the insights you bring with aria and other biotechs.

dough

[tony111]

Don,

534 was designed to be a pan BCR-ABL inhibitor rather than T315I specific. However, the management is looking for third-line now and other solid tumor indications. Maybe when the drug is approved they will run a head to head with Tasigna and Sprycel.